Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody

Catalog No. ABIN7581325

The Human Monoclonal anti-CEACAM5 (Labetuzumab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect CEACAM5 (Labetuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody (ABIN7581325)

Target: CEACAM5 (Labetuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CEACAM5 (Labetuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CEACAM5 (Labetuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab)

Characteristics: Anti-CEACAM5 / CEA / CD66e Reference Antibody (labetuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CEACAM5 (Labetuzumab Biosimilar)

Target: CEACAM5 (Labetuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P06731